§ PHARMACEUTICALS
USD · PharmaceuticalsOCUL
OCULAR THERAPEUTIX INC
USDSector · PharmaceuticalsBeta · 0.88
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
144 increased/new, 88 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 3.95 | EPS (TTM) | -1.46 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 32.7M | 0.0% | +3% |
| Deep Track Capital, LP | 19.7M | 2.7% | +144% |
| BlackRock, Inc. | 16.1M | 0.0% | +3% |
| Avoro Capital Advisors LLC | 12.3M | 1.0% | n/a |
| Summer Road LLC | 11.9M | 70.8% | +7% |
| Venrock Adviser, LLC | 10.3M | 3.3% | +41% |
◇ AC INTELLIGENCE
Top institutional owners for OCUL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER87.6% · 0 holders
OTHER7.5% · 189 holders
QUALITY / COMPOUNDER2.3% · 18 holders
PASSIVE / INDEX1.4% · 9 holders
DEALER / BANK0.7% · 27 holders
TACTICAL / MACRO0.3% · 5 holders
SYSTEMATIC / QUANT0.2% · 11 holders
INCOME / DEFENSIVE0.1% · 12 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for OCUL in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention OCUL yet.